InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Browse the detailed record of transactions filed by Boyd Peter E., See Remarks. Insider active across 1 companies, notably Aquestive Therapeutics, Inc.. Cumulatively, 8 disclosures have been published. Total volume traded: €371k. The latest transaction was disclosed on 15 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
US$60,10510,000 shares@ US$6.01050.0076% mcap33.0% of flow
Common Stock
SEC:0001214659-25-015046·
€60,10510,000 shares@ €6.01050.0076% mcap16.2% of flow
Common Stock
SEC:0001214659-25-015046:0·
US$54,01810,000 shares@ US$5.40180.0069% mcap29.6% of flow
Common Stock
SEC:0001214659-25-014287·
€54,01810,000 shares@ €5.40180.0069% mcap14.6% of flow
Common Stock
SEC:0001214659-25-014287:0·
US$68,20015,000 shares@ US$4.54670.0087% mcap37.4% of flow
Common Stock
SEC:0001214659-25-013485·
€68,20015,000 shares@ €4.54670.0087% mcap18.4% of flow
Common Stock
SEC:0001214659-25-013485:0·
€3,8795,000 shares@ €0.77580.0005% mcap1.0% of flow
Common Stock
SEC:0001628280-22-017186:0·
Ideal exit: 11 Mar 2023 (T+270)
€2,0542,293 shares@ €0.89570.0003% mcap0.6% of flow
Common Stock
SEC:0001628280-22-016872:0·
Ideal exit: 5 Mar 2023 (T+270)
8 of 8 declarations
About Boyd Peter E.
Boyd Peter E. is the SVP of Business Process and Information Technology at Aquestive Therapeutics, Inc. Although his role is classified as 'See Remarks', he is involved in essential functions that support the company's operations and enhance organizational efficiency.
